Psychological Illness is Commonly Associated with Functional Gastrointestinal Disorders and is Important to Consider During Patient Consultation: a Population-based Study

Overview

Journal BMC Med

Publisher Biomed Central

Specialty General Medicine

Date 2005 May 17

PMID 15892883

Citations 17

Authors

Ture Alander

Kurt Svardsudd

Sven-Erik Johansson

Lars Agreus

Affiliations

Soon will be listed here.

Abstract

Background: Some individuals with functional gastrointestinal disorders (FGID) suffer long-lasting symptoms without ever consulting their doctors. Our aim was to study co-morbidity and lifestyle differences among consulters and non-consulters with persistent FGID and controls in a defined adult population.

Methods: A random sample of the general adult Swedish population was obtained by a postal questionnaire. The Abdominal Symptom Questionnaire (ASQ) was used to measure GI symptomatology and grade of GI symptom severity and the Complaint Score Questionnaire (CSQ) was used to measure general symptoms. Subjects were then grouped for study by their symptomatic profiles. Subjects with long-standing FGID (n = 141) and subjects strictly free from gastrointestinal (GI) symptoms (n = 97) were invited to attend their local health centers for further assessment.

Results: Subjects with FGID have a higher risk of psychological illness [OR 8.4, CI95(4.0-17.5)] than somatic illness [OR 2.8, CI95(1.3-5.7)] or ache and fatigue symptoms [OR 4.3, CI95(2.1-8.7)]. Subjects with psychological illness have a higher risk of severe GI symptoms than controls; moreover they have a greater chance of being consulters. Patients with FGID have more severe GI symptoms than non-patients.

Conclusion: There is a strong relation between extra-intestinal, mental and somatic complaints and FGID in both patients and non-patients. Psychological illness increases the chance of concomitantly having more severe GI symptoms, which also enhance consultation behaviour.

Citing Articles

Efficacy of Nigella sativa seed oil against psychophysical stress induced irritable bowel syndrome and anxiety-like symptoms in Wistar rats.

Sharma M, Rana S, Aggarwal S, Ahsan A, Budhwar M, Mehra S Psychopharmacology (Berl). 2024; 241(12):2609-2626.

PMID: 39516296 DOI: 10.1007/s00213-024-06713-7.

The effects of gastrointestinal disturbances on the onset of depression and anxiety.

Cantarero-Prieto D, Moreno-Mencia P PLoS One. 2022; 17(1):e0262712.

PMID: 35077463 PMC: 8789191. DOI: 10.1371/journal.pone.0262712.

Sex and Gender Differences in Overlap Syndrome of Functional Gastrointestinal Disorder and Effect of Genetic Polymorphisms in South Korea: A Long-term Follow-up Study.

Lee J, Kim N, Park J, Yu J, Song Y, Yoon J J Neurogastroenterol Motil. 2022; 28(1):145-158.

PMID: 34980697 PMC: 8748849. DOI: 10.5056/jnm21047.

Altered fecal microbiota composition in individuals who abuse methamphetamine.

Yang Y, Yu X, Liu X, Liu G, Zeng K, Wang G Sci Rep. 2021; 11(1):18178.

PMID: 34518605 PMC: 8437956. DOI: 10.1038/s41598-021-97548-1.

From Infection to the Microbiome: An Evolving Role of Microbes in Schizophrenia.

Severance E, Yolken R Curr Top Behav Neurosci. 2019; 44:67-84.

PMID: 30847804 PMC: 6732248. DOI: 10.1007/7854_2018_84.

References

Agreus L, Svardsudd K, Nyren O, Tibblin G . Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care. 1993; 11(4):252-62. DOI: 10.3109/02813439308994840. View

Kettell J, Jones R, Lydeard S . Reasons for consultation in irritable bowel syndrome: symptoms and patient characteristics. Br J Gen Pract. 1992; 42(364):459-61. PMC: 1372267. View

Masand P, Kaplan D, Gupta S, Bhandary A . Irritable bowel syndrome and dysthymia. Is there a relationship?. Psychosomatics. 1997; 38(1):63-9. DOI: 10.1016/S0033-3182(97)71505-6. View

Sackett D . The rational clinical examination. A primer on the precision and accuracy of the clinical examination. JAMA. 1992; 267(19):2638-44. View

Westbrook J, McIntosh J, Talley N . Factors associated with consulting medical or non-medical practitioners for dyspepsia: an australian population-based study. Aliment Pharmacol Ther. 2000; 14(12):1581-8. DOI: 10.1046/j.1365-2036.2000.00878.x. View

Agreus L, Talley N, Svardsudd K, Tibblin G, Jones M . Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort, and bowel habit descriptors. Scand J Gastroenterol. 2000; 35(2):142-51. DOI: 10.1080/003655200750024308. View

Whitehead W, Palsson O, Jones K . Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology. 2002; 122(4):1140-56. DOI: 10.1053/gast.2002.32392. View

Haycox A, Einarson T, Eggleston A . The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999; 231:38-47. DOI: 10.1080/003655299750025255. View

McDougall N, Johnston B, Kee F, Collins J, McFarland R, Love A . Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut. 1996; 38(4):481-6. PMC: 1383100. DOI: 10.1136/gut.38.4.481. View

10.

Leong S, Barghout V, Birnbaum H, Thibeault C, Ben-Hamadi R, Frech F . The economic consequences of irritable bowel syndrome: a US employer perspective. Arch Intern Med. 2003; 163(8):929-35. DOI: 10.1001/archinte.163.8.929. View

11.

Whitehead W, Gibbs N, Li Z, Drossman D . Is functional dyspepsia just a subset of the irritable bowel syndrome?. Baillieres Clin Gastroenterol. 1999; 12(3):443-61. DOI: 10.1016/s0950-3528(98)90017-3. View

12.

Talley N, Boyce P, Jones M . Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut. 1998; 42(5):690-5. PMC: 1727099. DOI: 10.1136/gut.42.5.690. View

13.

Jones R, Lydeard S, Hobbs F, Kenkre J, Williams E, Jones S . Dyspepsia in England and Scotland. Gut. 1990; 31(4):401-5. PMC: 1378412. DOI: 10.1136/gut.31.4.401. View

14.

Agreus L, Svardsudd K, Nyren O, Tibblin G . Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995; 109(3):671-80. DOI: 10.1016/0016-5085(95)90373-9. View

15.

Masand P, Kaplan D, Gupta S, Bhandary A, Nasra G, Kline M . Major depression and irritable bowel syndrome: is there a relationship?. J Clin Psychiatry. 1995; 56(8):363-7. View

16.

Nyren O, Lindberg G, Lindstrom E, Marke LA , Seensalu R . Economic costs of functional dyspepsia. Pharmacoeconomics. 1992; 1(5):312-24. DOI: 10.2165/00019053-199201050-00003. View

17.

Lydiard R, Fossey M, Marsh W, Ballenger J . Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics. 1993; 34(3):229-34. DOI: 10.1016/S0033-3182(93)71884-8. View

18.

Ruigomez A, Wallander M, Johansson S, Garcia Rodriguez L . One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther. 1999; 13(8):1097-102. DOI: 10.1046/j.1365-2036.1999.00576.x. View

19.

Kane Jr F, Strohlein J, Harper R . Nonulcer dyspepsia associated with psychiatric disorder. South Med J. 1993; 86(6):641-6. DOI: 10.1097/00007611-199306000-00010. View

20.

Gupta S, Masand P, KAPLAN D, Bhandary A, Hendricks S . The relationship between schizophrenia and irritable bowel syndrome (IBS). Schizophr Res. 1997; 23(3):265-8. DOI: 10.1016/s0920-9964(96)00099-0. View